Primary vs. Secondary Low T
As men age or face certain health challenges, it’s common to hear about “low T” or testosterone deficiency. But what exactly is hypogonadism, and why does the distinction between its two main types matter? Hypogonadism is a condition where the body doesn’t produce enough testosterone, the hormone that supports muscle strength, energy, mood, and sexual health. This article explains the difference between primary and secondary hypogonadism, what causes each, and how they’re diagnosed and treated.
What Is Hypogonadism?
Testosterone is produced mainly in the testes, but production is directed by the brain. The hypothalamus and pituitary gland send signals, in the form of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), that tell the testes how much testosterone to produce. Hypogonadism occurs when this system breaks down, resulting in low testosterone levels alongside characteristic symptoms.
There are two main types, and they’re distinguished by where the breakdown happens: primary hypogonadism originates in the testes themselves, while secondary hypogonadism originates in the brain’s signalling system. Both become more common with age, but their underlying causes and treatment approaches differ.
Primary Hypogonadism: When the Testes Are the Root Issue
In primary hypogonadism, the testes are directly affected and underproduce testosterone even when the brain is sending strong signals to do so. On bloodwork, this shows up as low testosterone alongside high LH and FSH, since the brain is compensating for the lack of response by signalling harder.
Common causes include:
- Genetic conditions, such as Klinefelter syndrome, which affects testicular development
- Injury or illness, including trauma, mumps orchitis, or damage from chemotherapy or radiation
- Age-related testicular decline, which occurs gradually but can be accelerated by other health factors
Symptoms of primary hypogonadism often appear more pronounced and can include fatigue, reduced muscle mass, erectile difficulties, and in some cases breast tissue growth (gynaecomastia) or reduced bone density.
Secondary Hypogonadism: When the Brain’s Signal Is Disrupted
Secondary hypogonadism is more common, particularly in midlife, and results from the hypothalamus or pituitary gland failing to send adequate signals to otherwise healthy testes. On bloodwork, testosterone is low, but LH and FSH are also low or within the normal range, indicating the control system itself isn’t signalling properly.
Common contributors include:
- Obesity, since excess fat tissue can convert testosterone into oestrogen and promote inflammation that suppresses signalling
- Chronic stress, which raises cortisol in a way that can compete with testosterone production
- Medical conditions, including pituitary tumours, head injury, sleep apnoea, and diabetes
- Medications, particularly opioids and some steroid treatments
Symptoms tend to be subtler than primary hypogonadism and can include low energy, low mood, poor concentration, and reduced libido. Importantly, secondary hypogonadism is often more responsive to addressing the underlying cause, such as weight loss or treating sleep apnoea, than primary hypogonadism is.
How Hypogonadism Is Diagnosed
Diagnosis starts with a review of symptoms and health history, followed by blood testing. Because testosterone is highest in the morning, blood should be drawn early in the day, and clinical guidelines generally call for at least two separate morning readings to confirm a diagnosis.
Alongside testosterone, testing typically includes:
- LH and FSH, to distinguish primary hypogonadism (elevated) from secondary hypogonadism (low or normal)
- Prolactin and thyroid function, particularly if a pituitary cause is suspected
- Additional imaging, if bloodwork points toward a pituitary or hypothalamic issue
At PrimeLife, this is handled through a full clinical assessment: symptom review, repeat morning bloodwork, and further investigation where the results suggest a pituitary or structural cause rather than an age-related decline.
How Hypogonadism Is Treated
Treatment depends on the type and underlying cause.
For secondary hypogonadism, addressing the root cause often comes first. Weight loss, improved sleep, and treating conditions like sleep apnoea can meaningfully raise testosterone without medication in some men. Where medication is appropriate, options like clomiphene can stimulate the body’s own testosterone production without suppressing fertility, which makes it a useful option for men who want to preserve sperm production.
For primary hypogonadism, the testes themselves aren’t responding to signalling, so lifestyle changes alone are less likely to resolve the deficiency. Testosterone replacement therapy (TRT) is often the appropriate treatment, prescribed and monitored by a clinician who tracks bloodwork, prostate health, and red blood cell counts throughout treatment.
For men concerned about fertility, hCG (human chorionic gonadotropin) can be used alongside or instead of TRT to help maintain natural testosterone production and sperm output, since standard TRT alone can suppress fertility.
In both types, ongoing monitoring matters. Regular bloodwork tracks how the body is responding and screens for effects that testosterone therapy can have on red blood cell count and other markers.
A Programme Built Around You
At PrimeLife, hypogonadism is treated as a clinical picture, not a single blood result. Every patient has a consultation with a qualified prescriber, and treatment, whether that means lifestyle changes, medication like clomiphene or hCG, or TRT, is built around bloodwork that identifies which type of hypogonadism is present and why.
If low T symptoms have been affecting you, understanding whether the cause is primary or secondary is the first step toward the right treatment.
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Always seek the advice of your GP, pharmacist, or qualified healthcare professional before starting, stopping, or changing any treatment. A qualified prescriber must assess individual clinical suitability. PrimeLife only prescribes treatments following a full clinical assessment.
Thomas Harries MPharm IP
Independent Prescribing Pharmacist
Further Reading
